Literature DB >> 15630643

Incisional local anaesthesia versus placebo for pain relief after appendectomy in children--a double-blinded controlled randomised trial.

S I Jensen1, M Andersen, J Nielsen, N Qvist.   

Abstract

Incisional local anaesthesia is widely used for postoperative pain relief after surgery. We present the results of a double-blinded and randomised controlled study of incisional bupivacaine versus placebo in 68 children undergoing open appendectomy. The trial medicine (0.5 ml/kg) was infiltrated into the subcutis after wound closure. Patients with a weight below 40 kg received a bupivacaine concentration of 0.25 % and the patients above 40 kg a concentration of 0.5 %. During the first 24 hours after surgery the patients in the bupivacaine group received on average 0.065 mg morphine/kg and in the placebo group 0.073 mg/kg. This difference was not statistically significant. The patients in the bupivacaine group tended to experience pain relief for a longer period of time compared to the patients in the placebo group. However, the difference was not significant. In conclusion, the use of subcutaneous infiltration with bupivacaine in the wound after open appendectomy had no significant effect on the use of morphine during the first postoperative day in children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15630643     DOI: 10.1055/s-2004-821044

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  2 in total

1.  Effect of wound infiltration with bupivacaine on postoperative analgesia in neonates and infants undergoing major abdominal surgery: a pilot randomized controlled trial.

Authors:  Ruenreong Leelanukrom; Suwannee Suraseranivongse; Varanate Boonrukwanich; Siriluk Wechwinij
Journal:  J Anesth       Date:  2012-03-04       Impact factor: 2.078

2.  Effect of bupivacaine on postoperative pain and analgesics use after single-incision laparoscopic appendectomy: double-blind randomized study.

Authors:  Heon-Kyun Ha; Kyung-Goo Lee; Kang Kook Choi; Wan Sung Kim; Hyung Rae Cho
Journal:  Ann Surg Treat Res       Date:  2020-01-31       Impact factor: 1.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.